J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of Clinical Pharmacology and New Drugs, 1973; 13:3-14
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Praag, H. M.
Right arrow Articles by Korf, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Praag, H. M.
Right arrow Articles by Korf, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

4-Chloramphetamines. Chance and Trend in the Development of New Antidepressants

H. M. van Praag 1 and J. Korf 1

1 Department of Biological Psychiatry, Psychiatric University Clinic, State University, Groningen, The Netherlands.

The therapeutic effect of antidepressants is customarily related to their ability to enlarge the amounts of functionally active 5-hydroxytryptamine (5-HT) and/or noradrenaline (NA) in the brain. A further evaluation of this hypothesis has become possible with the development of some compounds with a selective effect on the central 5-HT metabolism, namely, p-chloro-N-methylamphetamine (CMA) and p-chloramphetamine (4-CA). To begin with, we studied the influence of CMA and 4-CA on the human 5-HT metabolism. On the basis of the biochemical activity of the compounds, the following predictions were made and tested: (1) CMA and 4-CA are antidepressants; (2) the antidepressant potency of 4-CA exceeds that of CMA; (3) CMA and 4-CA exert little influence on motor activity and are therefore selective mood improvers. The first prediction was confirmed, the other two predictions were not. The possible causes of these results are discussed and avenues of further investigation outlined. It is finally pointed out that the monamine hypotheses on the mechanism of action of antidepressants make it possible to set a trend for the search for new antidepressants and to elevate this research above the purely empirical level.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
S. Borson and M. A. Raskind
Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease
Neurology, May 1, 1997; 48(5_Suppl_6): 17S - 24S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American College of Clinical Pharmacology